Google Translate
РусскийРусский EnglishEnglish

Chiesi Espana, S.A.U.

Chiesi Espana, S.A.U.

Chiesi is an international pharmaceutical group dedicated to investigation, development, production, and commercialization of innovative medicines. Since its foundation in 1935 by Italian pharmacist Giacomo Chiesi, the company has a firm purpose: to provide innovative pharmaceutical solutions destined to improve individuals’ quality of life. At the end of the 1970s, the first foreign subsidiary was opened. The country chosen was Brazil. Thus, the Italian pharmaceutical company began to make its way internationally.

Chiesi bet for Spain in 1995. Since then, it invests large amounts of resources each year to develop and perfect innovative treatments to improve patients’ health and quality of life.

With a consolidated turnover of 1,571 million euros, we are among the 50 best pharmaceutical companies in the world. Our production activity is carried out in 3 plants located in Parma in Italy, in Blois in France and in Santana de Parnaiba in Brazil. We export to more than 90 countries with a direct presence in 26. There are more than 5.6000 people from Chiesi around the world, of which approximately more than 10% are dedicated to research and development activities.

Display:
Show:
Sort By:
Properties and indications: Clinwas ® – is an antibiotic which contains clindamycin phosphate 1.0 % and is intended for the topical treatment of comedones and acne: inhibits the growth of Propionibacterium acnes – anaerobic bacteria that infect the sebaceous glands; ..
$18.95
Properties and indications: Clinwas ® – is an antibiotic which contains clindamycin phosphate 1.0 % and is intended for the topical treatment of comedones and acne: inhibits the growth of Propionibacterium acnes – anaerobic bacteria that infect the sebaceous glands; reduces..
$18.95